ClinicalTrials.Veeva

Menu

Better Classification of Respiratory Amyloidosis (B-AR)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

Amyloidosis

Study type

Observational

Funder types

Other

Identifiers

NCT05862961
APHP220270

Details and patient eligibility

About

The B-AR project is based on a retrospective analysis of amyloidosis typing and the identification of their amylogenic protein.This work should be able to unite many clinicians, including pulmonologists and pathologists around a rare disease that still suffers from insufficient data.

Full description

The B-AR study will highlight the interest of proteomic analysis of amyloidosis compared to their identification by immunostaining. The objective is to reduce diagnostic wandering and to improve patient management. The typing of respiratory amyloidosis will allow a better characterization of the disease and thus, to propose a dedicated therapeutic management.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient > to 18 years with amyloidosis on a histological sample of the tracheobronchial or pulmonary tree.

Exclusion criteria

  • Subject receiving state medical aid
  • Subject deprived of freedom, or under a legal protective measure (example: patients under guardianship or curators)

Trial contacts and locations

0

Loading...

Central trial contact

Yurdagül UZUNHAN, Pr,MD, PhD; Magali COLOMBAT, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems